All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Clinical trial explores high-dose vitamin B3 as potential treatment for glioblastoma brain cancer

5h ago· 4 min readenNews

Summary

A clinical trial is exploring whether high doses of vitamin B3 (niacin) could help patients with glioblastoma, an aggressive and deadly brain cancer. Scientists discovered that niacin may help revive immune cells that tumors shut down, enabling them to attack cancer more effectively. Early results have been promising, with patients showing significantly better progression-free survival than expected. The article follows the story of Edward Waldner, a 55-year-old diagnosed with glioblastoma, highlighting the potential of this vitamin-based approach to improve outcomes against one of the deadliest brain cancers.

Source

Twitter / XClinical trial explores high-dose vitamin B3 as potential treatment for glioblastoma brain cancersciencedaily.com

Key quotes

· 3 pulled
The doctor said I had a mass on my brain and needed to see an oncologist.
For months, Edward (Ed) Waldner knew something wasn't right.
Early results have been promising, with patients showing significantly better progression-free survival than expected.
Snippet from the RSS feed
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive immune cells that tumors shut down, allowing them to att

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.